← Leaderboards
Robert J Aiello
Cybrexa, Inc.
$1,150,000
Attributed
$2,300,000
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2019–21$2M$1.5M$1M$500K$0
'19
'20
'21
Funding mix
By agency
NIH$2,300,000 · 1
By mechanism
R44$2,300,000 · 1
Top collaborators
- Vishwas Paralkar3 shared
Others in their field
Other Emerging Leaders on “Adenosine Diphosphate”
- Danielle L Swaney · University Of California, San Francisco$4,769,065
- Sarah Foster Adams · University Of New Mexico Health Scis Ctr$2,438,558
- Elizabeth Rendina-Ruedy · Mainehealth$2,249,231
- Juan Du · Van Andel Research Institute$2,176,303
- Yong Zhang · University Of Southern California$2,046,372
- Li Jia · Brigham And Women'S Hospital$2,010,462
Research focus
Adenosine DiphosphateAdenosine Diphosphate RiboseAdvanced DevelopmentAlkylating AgentsAmino AcidsBarrier To CareBaseBlood CirculationBone MarrowBone Marrow SuppressionBrca1 GeneBrca2 GeneCancer CellCancer PatientCell MembraneChemistryChemotherapyClinicClinical TrialsCytosolDefectDna DamageDna RepairAcidity
Grant awards (3)
Development of tumor-targeted PARP inhibitors for the treatment of solid cancers$820,611
R44 · FY2021 · CA
Development of tumor-targeted PARP inhibitors for the treatment of solid cancers$1,179,389
R44 · FY2020 · CA
Development of tumor-targeted PARP inhibitors for the treatment of solid cancers$300,000
R44 · FY2019 · CA